Centers of Cancer Nanotechnology Excellence (CCNEs)(U54)

archived

Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) solicits grant applications to establish a collaborative network of Centers for Cancer Nanotechnology Excellence (CCNEs) within the NCI Alliance for Nanotechnology in Cancer (The Alliance) program (http://nano.cancer.gov). Whereas CCNEs will form the core of the Alliance, they will be accompanied by smaller awards for cancer nanotechnology platform projects (CNPPs) and training programs. This initiative is open to all qualified applicants regardless of whether or not they participated in the previous issuance of the program. CCNEs are designed to link physical scientists, engineers, and technologists working at the nanoscale with cancer biologists and oncologists specializing in the diagnosis, prevention, and treatment of cancer to enable multi-disciplinary team research. CCNE awards will support the development of techniques and tools based on nanotechnology and applicable to: early disease diagnosis using in vitro assays and devices and in vivo imaging techniques; multifunctional therapeutic solutions; and techniques for cancer prevention and control. Multi-disciplinary research teams to be established should collectively have the breadth of expertise that would allow them to: (a) identify innovative research approaches and (b) demonstrate the translational potential of the technological solution in oncology. The overall goal is a rapid advance of nanotechnology discoveries and their transformation into cancer-relevant applications with a potential clinical utility.

High